Rachel Sprague

ORCID: 0000-0002-1003-1631 · 7 papers in corpus
article 2021
THE UTILITY OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY DURING IVF IN PATIENTS WITH DIFFERENT INFERTILITY DIAGNOSES
·doi:10.1016/j.fertnstert.2021.07.1033
article 2020
Catecholestradiol Activation of Adrenergic Receptors Induces Endometrial Cell Survival via p38 MAPK Signaling
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgaa866

CONTEXT: Enhanced levels of catecholestradiols, 2-hydroxyestradiol (2-OHE2) or 4-hydroxyestradiol (4-OHE2), are reported in endometriosis. During gestation, catecholestradiol activation of adrenergic receptors (AR) elevates estrogen recepto…

article 2019
GATA binding protein 2 expression at implantation window diminishes in women with adenomyosis: implications for impaired endometrial receptivity
·doi:10.1016/j.fertnstert.2019.07.956
article 2019
Propranolol inhibits catecholestrogen-induced human endometrial stromal cell survival mediated by p38 MAPK signaling: potential therapy for endometriosis
·doi:10.1016/j.fertnstert.2019.07.943
article 2019
α1D-adrenergic receptor expression in human endometrial stromal cells contributes to catecholestradiol-induced cell survival: implications for endometriosis
·doi:10.1016/j.fertnstert.2019.07.946
article 2019
β2-Adrenergic receptor expression in human endometrial endothelial cells potentially mediates 2-hydroxyestradiol-induced microvascular stabilization: implications for endometriosis
·doi:10.1016/j.fertnstert.2019.02.056
article 2018
Adenomyosis and its impact on fertility

Comorbidities such as endometriosis can confound the picture in patients with adenomyosis, a condition that may lead to poor IVF outcomes.